$FLOC

Flowco Holdings Inc. (FLOC): Results of Operations and Financial Condition

Flowco Holdings Inc. (FLOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 floc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Flowco Holdings Inc. Reports Second Quarter 2026 Results HOUSTON -- (BUSINESS WIRE) -- Flowco Holdings Inc. (NYSE: FLOC) (“Flowco” or the “Company”), a provider of production optimization, artificial lift and emissions manage

Original reporting
Published Aug 11, 2026, 10:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$FLOC
Bullish
medium confidence
Mentioned
$FLOC
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FLOCBullishMed
01

Why it matters

The filing provides a fresh quarterly earnings and cash flow snapshot, plus two dividend declarations (regular and special) with record and payable dates, which can affect near-term trading and income allocation decisions.

02

Market read

Traders can update models on Q2 profitability, cash generation, liquidity, and shareholder return timing based on the newly filed 8-K details.

03

What to watch

Investors may discount the dividend signal if free cash flow is sensitive to working capital or maintenance cost timing, and may scrutinize the Production Solutions margin decline tied to higher surface equipment costs.

Relevance 7/10Novelty 8/10Timing: pre-market today, after-hours? conference call scheduled Aug 11, 2026 8:00 a.m. ET

Background

Flowco filed an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting second quarter 2026 results and financial condition.

Company-level read

Ticker impact

$FLOCBullishMedium confidence
Context

Flowco reported Q2 2026 revenues of $235.9M, net income of $30.9M, and Adjusted EBITDA of $93.9M, plus $49.8M free cash flow.

Expected impact

Moderately positive bias for the next session(s), with follow-through risk if investors focus on segment margin softness (Natural Gas Technologies vapor recovery sales down).

Evidence & confidence

The filing includes multiple concrete datapoints (earnings, cash flow, liquidity) and two dividend declarations with specific payable dates, but it does not provide new guidance or a surprise event beyond the quarter results.

Market effects

Reinforces demand resilience for production optimization and artificial lift solutions in North America, while highlighting weakness in vapor recovery system sales.

Supports a constructive read-through for North American oilfield services tied to maximizing production and efficiency.

Limited, as the disclosure is company-specific and focused on North American customer demand and segment performance.

Counterpoint

Natural Gas Technologies revenue and Adjusted EBITDA declined sequentially, suggesting mixed end-market demand and potential margin pressure if vapor recovery weakness persists.

Key entities

  • Flowco Holdings Inc.

    Provider of production optimization, artificial lift, and emissions management and monetization solutions for oil and natural gas.

  • Flowco MergeCo LLC

    Operating subsidiary that will make a corresponding distribution for the regular quarterly dividend.

Related articles

Med

Flowco Holdings Inc. Q2 2026 Earnings Call Summary

Flowco Holdings reported Q2 2026 results driven by integrating Valiant, expanding its artificial lift portfolio into ESPs. Revenue rose 13%, with Production Solutions contributing via Downhole Components and Valiant. Management cited 40% adjusted EBITDA margins and guided Q3 adjusted EBITDA of $92 million to $98 million amid fuel and lubricant cost pressure.

$FLOCMed

Why is Flowco Holdings stock rallying today?

Flowco Holdings (FLOC) shares rose 4.7% in pre-open after it reported Q2 2026 results. Revenue was $235.9M, up 22.1% year over year and above forecasts. Adjusted EBITDA was $93.9M with a 39.8% margin, and free cash flow was $49.8M. EPS missed ($0.28 vs $0.45 consensus). The board declared a $0.14 special dividend payable Aug. 31.

$CPKMedAI 8/10

Chesapeake Utilities (CPK) Q2 2026 Earnings Call Transcript

Chesapeake Utilities (CPK) reported Q2 2026 adjusted net income of $25.4 million, up 5% year over year, and adjusted EPS of $1.05. Management raised 2026 capital guidance to $550 million to $600 million and expects 2028 EPS of $7.75 to $8.00. It also discussed the $1.2 billion Florida Energy Pathway project and reaffirmed efficiency and dividend plans.

$QNSTHighAI 9/10

QuinStreet (QNST) Q4 2026 Earnings Call Transcript

QuinStreet (QNST) reported Q4 FY2026 revenue of $373.9M, up 43% y/y, and full-year revenue of $1.3B, up 18% y/y, driven by Financial Services and Home Services. Adjusted EBITDA rose to $41.4M (11.1% margin). Non-GAAP EPS was $0.50 in Q4. Q1 2027 revenue guidance is $370M-$380M.

$AVPTMedAI 9/10

AvePoint (AVPT) Q2 2026 Earnings Call Transcript

AvePoint (AVPT) reported Q2 2026 revenue of $124.5M, up 22% YoY, with SaaS revenue $98.5M (79% of total). Total ARR was $465.1M (+27%), net new ARR $29.9M, and GAAP operating margin 8.2%. Full-year guidance: ARR $522.1M-$528.1M and revenue $508.5M-$512.5M. The company also spent $50M on share repurchases in Q2.

$NUTXMedAI 8/10

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported Q2 2026 results on an earnings call. Total revenue fell to $210.8M from $244.0M. Net income rose to $65.8M, diluted EPS to $9.38, and adjusted EBITDA to $90.0M. Management cited lower contract services costs from a HaloMD amendment and higher patient visits, plus a hospital expansion pipeline.